Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Omega 3 Gummies Market

Published Date : Nov 2022

Omega-3 fatty acids are a type of fat that cannot be produced by the body. Fish is the best dietary source of omega-3 fatty acids. Some plants also contain omega-3 fatty acids. There are two types of omega-3 fatty acids found in fish, eicosapentaenoic acid (EPA) and d... View more

Coherent Market Insights Sodium Selenite Market

Published Date : Nov 2022

Sodium selenite appears as a crystalline solid with a white tint. Contact with sodium selenite may irritate mucous membranes, eyes, and skin. It is toxic when ingested, inhaled, or absorbed through the skin. A 2:1 ratio of sodium and selenite ions make ... View more

Coherent Market Insights Eye Inflammation Treatment Market

Published Date : Nov 2022

Eye inflammation, also known as ocular inflammation, is a disorder marked by the swelling of one or more eye regions and can be brought on by a number of different things, from minor irritation to specific illnesses. Eye Inflammation is classified according to the par... View more

Coherent Market Insights Sertraline Hcl Market

Published Date : Nov 2022

Sertraline HCl belongs to a class of antidepressants known as selective serotonin reuptake inhibitors (SSRIs). Sertraline HCl has the same mechanism of action as other SSRIs. It works by increasing the amount of serotonin that is available in the brain. Serotonin is a... View more

Coherent Market Insights Us Diabetic Neuropathy Market

Published Date : Nov 2022

Diabetic neuropathy is a serious and common complication of type 1 and type 2 diabetes. Diabetic neuropathy is the damage caused to the nerve due to diabetes which often leads to pain and numbness in feet or lower leg, it develops slowly, sometimes over the course of ... View more

Coherent Market Insights Cattle Healthcare Market

Published Date : Nov 2022

Cattle healthcare is one of the major aspects of animal husbandry as it has direct co-relation with productivity and outcome from animal husbandry. Several countries worldwide are focusing more on the cattle health to improve the health and welfare of cattle and imple... View more

Coherent Market Insights Us Compounding Pharmacies Market

Published Date : Nov 2022

A pharmacy that is operated by a licensed pharmacist, licensed physician or a person under the guidance of a licensed pharmacist is called compounding pharmacy. The process of combining, blending, or modifying substances to make a treatment specific to the requirement... View more

Coherent Market Insights Primary Sclerosing Cholangitis Market

Published Date : Nov 2022

Primary sclerosing cholangitis (PSC) is generally a progressive disease that eventually culminates in cirrhosis with complications (portal hypertension, end-stage liver disease, and hepatic failure). Bile ducts carry the digestive liquid bile from liver to small intes... View more

Coherent Market Insights Ependymoma Drug Market

Published Date : Nov 2022

Ependymoma is a rare type of brain tumour called a glioma. It starts from ependymal cells in the brain or spinal cord. Ependymomas can develop in children and adults. They are soft, grayish, or red tumors which may contain cysts or mineral calcifications. Symptoms of ... View more

Coherent Market Insights Dermatomyositis Drug Market

Published Date : Nov 2022

Dermatomyositis (DM) is a rare inflammatory muscle disease that affects both the muscles as well as the skin. Dermatomyositis can strike people of all races, genders, and ages. Although, both males and females are affected equally in childhood, it is more common in fe... View more

Coherent Market Insights Congenital Hyperinsulinism Treatment Market

Published Date : Nov 2022

Congenital hyperinsulinism(CHI) also called as hyperinsulinemic hypoglycemia, a rare endocrine condition that causes low blood glucose levels and occurs mainly in newborn babies, infants and children leading to permanent brain injury and is most frequent cause of seve... View more

Coherent Market Insights Ischemic Neurological Interventional Medical Devices Market

Published Date : Nov 2022

Medical device is an apparatus, machine, tool, instrument, in vitro reagent, or similar the product that mitigate, treat, diagnose, prevent, cure a disease and its purpose is to achieve physical, structural and mechanical action with or within the body. Medical device... View more

Coherent Market Insights Antibiotics Market

Published Date : Nov 2022

Antibiotics are medicines that fight bacterial infections in people and animals. These drugs help destroy or slow down the growth of bacteria. Antibiotics either kill bacteria or stop them from reproducing, allowing the body to eliminate pathogens. When used properly,... View more

Coherent Market Insights Preclinical Assets Market

Published Date : Nov 2022

Preclinical assets consist of various types of services such as Bioanalysis and DMPK (Drug Metabolism and pharmacokinetics) studies, which are further sub segmented into in vitro and in vivo analysis, toxicology testing, which are based on GLP and non GLP (Good Labora... View more

Coherent Market Insights Human Insulin Drug Market

Published Date : Nov 2022

Insulin is a pharmaceutical preparation used to control high blood glucose (blood sugar level). It is used to control blood sugar in people with type 1 and type 2 diabetes. People with diabetes require insulin as part of their treatment. It works by helping move sugar... View more

Coherent Market Insights Attention Deficit Hyperactivity Disorder Treatment Market

Published Date : Oct 2022

The global attention deficit hyperactivity disorder (ADHD) treatment market comprises therapeutics used for the treatment of attention deficit hyperactivity disorder. There are various therapeutics such as stimulants, which include stimulant drugs such as Amphetamine,... View more

Coherent Market Insights Rx Medical Food Market

Published Date : Oct 2022

Medical food is a category of food products for dietary management or preventive therapy for specific disease or medical conditions such as pulmonary, gastrointestinal, and metabolic disorders. Ingredients used in medical foods must have ‘generally recognized as... View more

Coherent Market Insights Chronic Kidney Disease Drugs Market

Published Date : Oct 2022

Chronic kidney disease is a condition which is characterized by gradual loss of kidney function over time. Chronic kidney disease is also known as chronic renal disease. The kidney disease gets worse, wastes can build to high levels in your blood; other problems assoc... View more

Coherent Market Insights Dental Caries Treatment Market

Published Date : Oct 2022

Dental caries (tooth decay or dental cavities) is the most common noncommunicable disease worldwide. It is the most prevalent chronic disease in both children and adults, even though it is largely preventable. Severe dental caries affects general health and often caus... View more

Coherent Market Insights Methotrexate Drugs Market

Published Date : Oct 2022

Methotrexate is a type of disease-modifying anti-rheumatic drug (DMARD). It is used to reduce the activity of the immune system for people who have certain conditions. The immune system normally protects the body from infections by causing inflammation to fight them. ... View more

© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.